Pharma companies win reversal of US fraud pricing verdicts
21 October 2009
Nancy Faigen
The Alabama Supreme Court has overturned two jury verdicts against three pharmaceutical manufacturers awarding the state more than $274 million. The court ruled there was no basis for the state's claims that
AstraZeneca,
Novartis and GlaxoSmithKline committed fraud by manipulating average wholesale...
Please Login to read the full article.
21 October 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Supreme Court rules against statistically significant 'bright-line' rule in Matrixx
- J&J to pay $158M to settle Texas Medicaid fraud case
- US FDA warns public of fraudulent stem cell schemes
- US Capitol Capsule: Supreme Court to weigh generic drug liability, patent burden-of-proof standards
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
